Report Detail

Pharma & Healthcare Global Brucella Abortus Vaccine Market Insights and Forecast to 2026

  • RnM4165177
  • |
  • 26 August, 2020
  • |
  • Global
  • |
  • 150 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Brucella Abortus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brucella Abortus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Brucella Abortus Vaccine market is segmented into
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others

Segment by Application, the Brucella Abortus Vaccine market is segmented into
Cattles
Sheep
Pigs
Others

Regional and Country-level Analysis
The Brucella Abortus Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Brucella Abortus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Brucella Abortus Vaccine Market Share Analysis
Brucella Abortus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Brucella Abortus Vaccine business, the date to enter into the Brucella Abortus Vaccine market, Brucella Abortus Vaccine product introduction, recent developments, etc.

The major vendors covered:
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health


1 Study Coverage

  • 1.1 Brucella Abortus Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Brucella Abortus Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Type
    • 1.4.2 DNA Vaccines
    • 1.4.3 Subunit Vaccines
    • 1.4.4 Vector Vaccines
    • 1.4.5 B. Abortus Recombinant Mutants
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Application
    • 1.5.2 Cattles
    • 1.5.3 Sheep
    • 1.5.4 Pigs
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Brucella Abortus Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Brucella Abortus Vaccine Revenue 2015-2026
    • 2.1.2 Global Brucella Abortus Vaccine Sales 2015-2026
  • 2.2 Global Brucella Abortus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Brucella Abortus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Brucella Abortus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Brucella Abortus Vaccine Competitor Landscape by Players

  • 3.1 Brucella Abortus Vaccine Sales by Manufacturers
    • 3.1.1 Brucella Abortus Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Brucella Abortus Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Brucella Abortus Vaccine Revenue by Manufacturers
    • 3.2.1 Brucella Abortus Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Brucella Abortus Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Brucella Abortus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Brucella Abortus Vaccine Revenue in 2019
    • 3.2.5 Global Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Brucella Abortus Vaccine Price by Manufacturers
  • 3.4 Brucella Abortus Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Brucella Abortus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Brucella Abortus Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Brucella Abortus Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Brucella Abortus Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Brucella Abortus Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Brucella Abortus Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Brucella Abortus Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Brucella Abortus Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Brucella Abortus Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Brucella Abortus Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Brucella Abortus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Brucella Abortus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Brucella Abortus Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Brucella Abortus Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Brucella Abortus Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Brucella Abortus Vaccine Price by Application (2015-2020)
  • 5.2 Brucella Abortus Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Brucella Abortus Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Brucella Abortus Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Brucella Abortus Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Brucella Abortus Vaccine by Country
    • 6.1.1 North America Brucella Abortus Vaccine Sales by Country
    • 6.1.2 North America Brucella Abortus Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Brucella Abortus Vaccine Market Facts & Figures by Type
  • 6.3 North America Brucella Abortus Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Brucella Abortus Vaccine by Country
    • 7.1.1 Europe Brucella Abortus Vaccine Sales by Country
    • 7.1.2 Europe Brucella Abortus Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Brucella Abortus Vaccine Market Facts & Figures by Type
  • 7.3 Europe Brucella Abortus Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Brucella Abortus Vaccine by Region
    • 8.1.1 Asia Pacific Brucella Abortus Vaccine Sales by Region
    • 8.1.2 Asia Pacific Brucella Abortus Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Brucella Abortus Vaccine by Country
    • 9.1.1 Latin America Brucella Abortus Vaccine Sales by Country
    • 9.1.2 Latin America Brucella Abortus Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Brucella Abortus Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Brucella Abortus Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Brucella Abortus Vaccine by Country
    • 10.1.1 Middle East and Africa Brucella Abortus Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Brucella Abortus Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Zoetis
    • 11.1.1 Zoetis Corporation Information
    • 11.1.2 Zoetis Description and Business Overview
    • 11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Zoetis Brucella Abortus Vaccine Products Offered
    • 11.1.5 Zoetis Related Developments
  • 11.2 CEVA
    • 11.2.1 CEVA Corporation Information
    • 11.2.2 CEVA Description and Business Overview
    • 11.2.3 CEVA Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 CEVA Brucella Abortus Vaccine Products Offered
    • 11.2.5 CEVA Related Developments
  • 11.3 Merck Animal Health
    • 11.3.1 Merck Animal Health Corporation Information
    • 11.3.2 Merck Animal Health Description and Business Overview
    • 11.3.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck Animal Health Brucella Abortus Vaccine Products Offered
    • 11.3.5 Merck Animal Health Related Developments
  • 11.4 Biovet
    • 11.4.1 Biovet Corporation Information
    • 11.4.2 Biovet Description and Business Overview
    • 11.4.3 Biovet Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Biovet Brucella Abortus Vaccine Products Offered
    • 11.4.5 Biovet Related Developments
  • 11.5 CAVAC
    • 11.5.1 CAVAC Corporation Information
    • 11.5.2 CAVAC Description and Business Overview
    • 11.5.3 CAVAC Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 CAVAC Brucella Abortus Vaccine Products Offered
    • 11.5.5 CAVAC Related Developments
  • 11.6 JOVAC
    • 11.6.1 JOVAC Corporation Information
    • 11.6.2 JOVAC Description and Business Overview
    • 11.6.3 JOVAC Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 JOVAC Brucella Abortus Vaccine Products Offered
    • 11.6.5 JOVAC Related Developments
  • 11.7 Merial
    • 11.7.1 Merial Corporation Information
    • 11.7.2 Merial Description and Business Overview
    • 11.7.3 Merial Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Merial Brucella Abortus Vaccine Products Offered
    • 11.7.5 Merial Related Developments
  • 11.8 Colorado Serum Company
    • 11.8.1 Colorado Serum Company Corporation Information
    • 11.8.2 Colorado Serum Company Description and Business Overview
    • 11.8.3 Colorado Serum Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Colorado Serum Company Brucella Abortus Vaccine Products Offered
    • 11.8.5 Colorado Serum Company Related Developments
  • 11.9 VECOL
    • 11.9.1 VECOL Corporation Information
    • 11.9.2 VECOL Description and Business Overview
    • 11.9.3 VECOL Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 VECOL Brucella Abortus Vaccine Products Offered
    • 11.9.5 VECOL Related Developments
  • 11.10 Tecnovax
    • 11.10.1 Tecnovax Corporation Information
    • 11.10.2 Tecnovax Description and Business Overview
    • 11.10.3 Tecnovax Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Tecnovax Brucella Abortus Vaccine Products Offered
    • 11.10.5 Tecnovax Related Developments
  • 11.1 Zoetis
    • 11.1.1 Zoetis Corporation Information
    • 11.1.2 Zoetis Description and Business Overview
    • 11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Zoetis Brucella Abortus Vaccine Products Offered
    • 11.1.5 Zoetis Related Developments
  • 11.12 Vetal
    • 11.12.1 Vetal Corporation Information
    • 11.12.2 Vetal Description and Business Overview
    • 11.12.3 Vetal Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Vetal Products Offered
    • 11.12.5 Vetal Related Developments
  • 11.13 Dollvet
    • 11.13.1 Dollvet Corporation Information
    • 11.13.2 Dollvet Description and Business Overview
    • 11.13.3 Dollvet Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Dollvet Products Offered
    • 11.13.5 Dollvet Related Developments
  • 11.14 Centro Diagnostico Veterinario
    • 11.14.1 Centro Diagnostico Veterinario Corporation Information
    • 11.14.2 Centro Diagnostico Veterinario Description and Business Overview
    • 11.14.3 Centro Diagnostico Veterinario Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Centro Diagnostico Veterinario Products Offered
    • 11.14.5 Centro Diagnostico Veterinario Related Developments
  • 11.15 Onderstepoort Biological Products
    • 11.15.1 Onderstepoort Biological Products Corporation Information
    • 11.15.2 Onderstepoort Biological Products Description and Business Overview
    • 11.15.3 Onderstepoort Biological Products Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Onderstepoort Biological Products Products Offered
    • 11.15.5 Onderstepoort Biological Products Related Developments
  • 11.16 Institute of Animal Health and Veterinary Biologicals
    • 11.16.1 Institute of Animal Health and Veterinary Biologicals Corporation Information
    • 11.16.2 Institute of Animal Health and Veterinary Biologicals Description and Business Overview
    • 11.16.3 Institute of Animal Health and Veterinary Biologicals Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Institute of Animal Health and Veterinary Biologicals Products Offered
    • 11.16.5 Institute of Animal Health and Veterinary Biologicals Related Developments
  • 11.17 Biogenesis Bago
    • 11.17.1 Biogenesis Bago Corporation Information
    • 11.17.2 Biogenesis Bago Description and Business Overview
    • 11.17.3 Biogenesis Bago Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Biogenesis Bago Products Offered
    • 11.17.5 Biogenesis Bago Related Developments
  • 11.18 Instituto Rosenbusch
    • 11.18.1 Instituto Rosenbusch Corporation Information
    • 11.18.2 Instituto Rosenbusch Description and Business Overview
    • 11.18.3 Instituto Rosenbusch Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Instituto Rosenbusch Products Offered
    • 11.18.5 Instituto Rosenbusch Related Developments
  • 11.19 SYVA Laboratorios
    • 11.19.1 SYVA Laboratorios Corporation Information
    • 11.19.2 SYVA Laboratorios Description and Business Overview
    • 11.19.3 SYVA Laboratorios Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 SYVA Laboratorios Products Offered
    • 11.19.5 SYVA Laboratorios Related Developments
  • 11.20 CZ Veterinaria
    • 11.20.1 CZ Veterinaria Corporation Information
    • 11.20.2 CZ Veterinaria Description and Business Overview
    • 11.20.3 CZ Veterinaria Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 CZ Veterinaria Products Offered
    • 11.20.5 CZ Veterinaria Related Developments
  • 11.21 Hester Biosciences
    • 11.21.1 Hester Biosciences Corporation Information
    • 11.21.2 Hester Biosciences Description and Business Overview
    • 11.21.3 Hester Biosciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.21.4 Hester Biosciences Products Offered
    • 11.21.5 Hester Biosciences Related Developments
  • 11.22 Qilu Animal Health
    • 11.22.1 Qilu Animal Health Corporation Information
    • 11.22.2 Qilu Animal Health Description and Business Overview
    • 11.22.3 Qilu Animal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.22.4 Qilu Animal Health Products Offered
    • 11.22.5 Qilu Animal Health Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Brucella Abortus Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Brucella Abortus Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Brucella Abortus Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Brucella Abortus Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Brucella Abortus Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Brucella Abortus Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Brucella Abortus Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Brucella Abortus Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Brucella Abortus Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Brucella Abortus Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Brucella Abortus Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Brucella Abortus Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Brucella Abortus Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Brucella Abortus Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Brucella Abortus Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Brucella Abortus Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Brucella Abortus Vaccine. Industry analysis & Market Report on Brucella Abortus Vaccine is a syndicated market report, published as Global Brucella Abortus Vaccine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Brucella Abortus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,053.70
    4,580.55
    6,107.40
    3,588.00
    5,382.00
    7,176.00
    612,456.00
    918,684.00
    1,224,912.00
    324,441.00
    486,661.50
    648,882.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report